Skip to main content

RETRACTION article

Front. Mol. Biosci.
Sec. Molecular Diagnostics and Therapeutics
Volume 12 - 2025 | doi: 10.3389/fmolb.2025.1561889

Retraction: ZFP36 Binds With PRC1 to Inhibit Tumor Growth and Increase 5-Fu Chemosensitivity of Hepatocellular Carcinoma

Provisionally accepted
Frontiers Editorial Office Frontiers Editorial Office *
  • Frontiers Media SA, Lausanne, Switzerland

This article is a retraction of:

  1. ZFP36 Binds With PRC1 to Inhibit Tumor Growth and Increase 5-Fu Chemosensitivity of Hepatocellular Carcinoma

    1. Read original article

The final, formatted version of the article will be published soon.

    Please find the retraction statement below:Chen W, Chen M, Zhao Z, Weng Q, Song J, Fang S, Wu X, Wang H, Zhang D, Yang W, Wang Z, Xu M, Ji J (2020) ZFP36 Binds With PRC1 to Inhibit Tumor Growth and Increase 5-Fu Chemosensitivity of Hepatocellular Carcinoma. Front. Mol. Biosci. 7:553740. doi: 10.3389/fmolb.2020.00126Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers' policies.This retraction was approved by the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and do not agree to this retraction. This communication has been recorded by the publisher.

    Keywords: Hepatocellular Carcinoma, ZFP36, PRC1, 5-FU, Migration, invasion

    Received: 16 Jan 2025; Accepted: 16 Jan 2025.

    Copyright: © 2025 Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Frontiers Editorial Office, Frontiers Media SA, Lausanne, Switzerland

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.